Item 2.02. Results of Operations and Financial Condition.

On August 4, 2021, Protagonist Therapeutics, Inc. reported its financial results for the quarter ended June 30, 2021. A copy of the press release titled "Protagonist Therapeutics Reports Second Quarter 2021 Financial Results and Recent Company Progress" is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.                                 Description
  99.1          Press release, dated August 4, 2021, titled "Protagonist Therapeutics
              Reports Second Quarter 2021 Financial Results and Recent Company
              Progess."
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Protagonist Therapeutics, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.

© Edgar Online, source Glimpses